Abl kinases are required for vascular function, Tie2 expression, and angiopoietin-1-mediated survival

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 30, 2013, Pages 12432-12437

  Chislock, Elizabeth M ^a   Ring, Colleen ^a   Pendergast, Ann Marie ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abl tyrosine kinases; Fibrosis; Heart defects; Thrombosis

Indexed keywords

ABELSON KINASE; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMEGALY; CARDIOVASCULAR FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; GENE DELETION; HOMEOSTASIS; LETHALITY; MOUSE; NONHUMAN; NULL ALLELE; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SCAR FORMATION; SIGNAL TRANSDUCTION; TISSUE INJURY; TISSUE NECROSIS;

ABL TYROSINE KINASES; FIBROSIS; HEART DEFECTS; THROMBOSIS;

ANGIOPOIETIN-1; APOPTOSIS; BLOOD VESSELS; CARDIOMEGALY; CELL SURVIVAL; GENES, LETHAL; HUMANS; PROTEIN-TYROSINE KINASES; PULMONARY FIBROSIS; RECEPTOR, TIE-2; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 84880692698     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1304188110     Document Type: Article

References (34)

1. Carmeliet P (2003) Angiogenesis in health and disease. Nat Med 9(6):653-660.
2. Cines DB, et al. (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91(10):3527-3561.
3. Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438(7070): 967-974.
4. Koh GY (2013) Orchestral actions of angiopoietin-1 in vascular regeneration. Trends Mol Med 19(1):31-39.
5. Thomas M, Augustin HG (2009) The role of the Angiopoietins in vascular morphogenesis. Angiogenesis 12(2):125-137.
6. Ferrara N, et al. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380(6573):439-442.
7. Sato TN, et al. (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376(6535):70-74.
8. Augustin HG, Koh GY, Thurston G, Alitalo K (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10(3):165-177.
9. Lee S, et al. (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130(4):691-703.
10. Pendergast AM (2002) The Abl family kinases: Mechanisms of regulation and signaling. Adv Cancer Res 85:51-100.
11. Zandy NL, Playford M, Pendergast AM (2007) Abl tyrosine kinases regulate cell-cell adhesion through Rho GTPases. Proc Natl Acad Sci USA 104(45):17686-17691.
12. Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D (1986) The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science 233(4760):212-214.
13. Koleske AJ, et al. (1998) Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21(6):1259-1272.
14. Kerkelä R, et al. (2006) Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med 12(8):908-916.
15. Qiu Z, Cang Y, Goff SP (2010) c-Abl tyrosine kinase regulates cardiac growth and development. Proc Natl Acad Sci USA 107(3):1136-1141.
16. Aichberger KJ, et al. (2011) Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML. Am J Hematol 86(7):533-539.
17. Quintás-Cardama A, Kantarjian H, Cortes J (2012) Nilotinib-associated vascular events. Clin Lymphoma Myeloma Leuk 12(5):337-340.
18. Aman J, et al. (2012) Effective treatment of edema and endothelial barrier dysfunction with imatinib. Circulation 126(23):2728-2738.
19. Dudek SM, et al. (2010) Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function. Mol Biol Cell 21(22):4042-4056.
20. Voelkel NF, et al.; National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure (2006) Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 114(17):1883-1891.
21. Gehlbach BK, Geppert E (2004) The pulmonary manifestations of left heart failure. Chest 125(2):669-682.
22. Burton EA, Plattner R, Pendergast AM (2003) Abl tyrosine kinases are required for infection by Shigella flexneri. EMBO J 22(20):5471-5479.
23. Jones N, et al. (2001) Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO Rep 2(5):438-445.
24. Kwak HJ, So JN, Lee SJ, Kim I, Koh GY (1999) Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett 448(2-3):249-253.
25. Kim I, et al. (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. Circ Res 86(1):24-29.
26. Kisanuki YY, et al. (2001) Tie2-Cre transgenic mice: A new model for endothelial celllineage analysis in vivo. Dev Biol 230(2):230-242.
27. Park YH, et al. (2006) BNP as a marker of the heart failure in the treatment of imatinib mesylate. Cancer Lett 243(1):16-22.
28. Turrisi G, et al. (2010) Congestive heart failure during imatinib mesylate treatment. Int J Cardiol 145(1):148-150.
29. Peerzada MM, Spiro TP, Daw HA (2011) Pulmonary toxicities of tyrosine kinase inhibitors. Clin Adv Hematol Oncol 9(11):824-836.
30. Brindle NP, Saharinen P, Alitalo K (2006) Signaling and functions of angiopoietin-1 in vascular protection. Circ Res 98(8):1014-1023.
31. Bhandari V, et al. (2006) Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 12(11):1286-1293.
32. Lim HS, Blann AD, Chong AY, Freestone B, Lip GY (2004) Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: Implications for cardiovascular risk and effects of multifactorial intervention. Diabetes Care 27(12):2918-2924.
33. Parikh SM, et al. (2006) Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 3(3):e46.
34. Moresco EM, Donaldson S, Williamson A, Koleske AJ (2005) Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases. J Neurosci 25(26): 6105-6118.